Star Lake BioscienceZhaoqing Guangdong Balance Sheet Health
Financial Health criteria checks 5/6
Star Lake BioscienceZhaoqing Guangdong has a total shareholder equity of CN¥7.8B and total debt of CN¥3.8B, which brings its debt-to-equity ratio to 49.1%. Its total assets and total liabilities are CN¥14.3B and CN¥6.5B respectively. Star Lake BioscienceZhaoqing Guangdong's EBIT is CN¥1.4B making its interest coverage ratio 12.1. It has cash and short-term investments of CN¥2.0B.
Key information
49.1%
Debt to equity ratio
CN¥3.81b
Debt
| Interest coverage ratio | 12.1x |
| Cash | CN¥2.01b |
| Equity | CN¥7.76b |
| Total liabilities | CN¥6.54b |
| Total assets | CN¥14.31b |
Recent financial health updates
Recent updates
Why Star Lake BioscienceZhaoqing Guangdong's (SHSE:600866) Earnings Are Better Than They Seem
Nov 04
Star Lake BioscienceZhaoqing Guangdong (SHSE:600866) Seems To Use Debt Quite Sensibly
Oct 27Little Excitement Around Star Lake Bioscience Co., Inc.Zhaoqing Guangdong's (SHSE:600866) Earnings
Sep 25Star Lake BioscienceZhaoqing Guangdong (SHSE:600866) Ticks All The Boxes When It Comes To Earnings Growth
Jul 26Estimating The Intrinsic Value Of Star Lake Bioscience Co., Inc.Zhaoqing Guangdong (SHSE:600866)
May 28There's No Escaping Star Lake Bioscience Co., Inc.Zhaoqing Guangdong's (SHSE:600866) Muted Earnings Despite A 26% Share Price Rise
Apr 29Financial Position Analysis
Short Term Liabilities: 600866's short term assets (CN¥5.1B) exceed its short term liabilities (CN¥4.4B).
Long Term Liabilities: 600866's short term assets (CN¥5.1B) exceed its long term liabilities (CN¥2.1B).
Debt to Equity History and Analysis
Debt Level: 600866's net debt to equity ratio (23.2%) is considered satisfactory.
Reducing Debt: 600866's debt to equity ratio has increased from 18.3% to 49.1% over the past 5 years.
Debt Coverage: 600866's debt is well covered by operating cash flow (57%).
Interest Coverage: 600866's interest payments on its debt are well covered by EBIT (12.1x coverage).